Teligene has raised over 600 million yuan ($93 million) in its pre-IPO round from GTJA Investment Group, while AnchorDx has raked in $40 million in its Series C round jointly led by OrbiMed and Wuxi Huiying Investment.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
